CAPTRUST Financial Advisors
INAB icon

CAPTRUST Financial Advisors’s IN8bio INAB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.3K Buy
33,295
+15,000
+82% +$29K ﹤0.01% 2898
2025
Q4 		$42.8K Buy
+18,295
New +$34.8K ﹤0.01% 2690

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

CAPTRUST Financial Advisors's INAB Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its IN8bio (INAB) stake by 82% in Q1 2026, buying an estimated $29K and bringing the position to 33,295 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2898.

CAPTRUST Financial Advisors first reported a position in INAB in Q4 2025 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • CAPTRUST Financial Advisors held 33,295 shares of IN8bio worth $49.3K as of Q1 2026.
  • CAPTRUST Financial Advisors bought 15,000 IN8bio shares in Q1 2026, an estimated $29K.
  • IN8bio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2898 holding.
  • CAPTRUST Financial Advisors first reported a position in IN8bio in Q4 2025 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.